Credit Suisse’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $30.2M | Buy |
994,993
+191,288
| +24% | +$5.81M | 0.03% | 519 |
|
|
2023
Q4 | $22.6M | Buy |
803,705
+134,654
| +20% | +$3.78M | 0.02% | 628 |
|
|
2023
Q3 | $18.2M | Sell |
669,051
-2,468
| -0.4% | -$67K | 0.02% | 657 |
|
|
2023
Q2 | $20.6M | Buy |
671,519
+170,988
| +34% | +$5.26M | 0.02% | 644 |
|
|
2023
Q1 | $18M | Buy |
500,531
+90,024
| +22% | +$3.24M | 0.02% | 695 |
|
|
2022
Q4 | $16.2M | Sell |
410,507
-3,891
| -0.9% | -$154K | 0.02% | 728 |
|
|
2022
Q3 | $16.7M | Buy |
414,398
+15,788
| +4% | +$634K | 0.02% | 715 |
|
|
2022
Q2 | $16.8M | Buy |
398,610
+28,629
| +8% | +$1.2M | 0.02% | 741 |
|
|
2022
Q1 | $14.4M | Buy |
369,981
+105,189
| +40% | +$4.1M | 0.01% | 880 |
|
|
2021
Q4 | $10.6M | Buy |
264,792
+109,480
| +70% | +$4.36M | 0.01% | 1082 |
|
|
2021
Q3 | $5.61M | Buy |
155,312
+4,428
| +3% | +$160K | ﹤0.01% | 1449 |
|
|
2021
Q2 | $6.19M | Buy |
150,884
+34,937
| +30% | +$1.43M | ﹤0.01% | 1415 |
|
|
2021
Q1 | $5.06M | Buy |
115,947
+39,568
| +52% | +$1.73M | ﹤0.01% | 1538 |
|
|
2020
Q4 | $3.82M | Buy |
+76,379
| New | +$3.82M | ﹤0.01% | 1707 |
|